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Aim: To investigate the renal expression of apoptosis regulatory proteins b-cell lymphoma 2 (bcl-2) and bcl-2 associated X (bax) in
children with Henoch–Schönlein nephritis (HSN)
Materials and methods: Renal expression of antiapoptotic bcl-2 and proapoptotic bax proteins were studied immunohistochemically in
22 children with HSN. The kidneys of 5 children who died due to nonrenal reasons were used as the control. The patients were compared
according to their renal histopathology and prognosis.
Results: Nephrotic or nephrotic-nephritic renal involvement was the most common presentation. Histopathological findings were
Class I in 1, Class II in 5, Class III in 10, Class IV in 4, and Class V in 2 patients. IgA staining was shown in all biopsies. Bcl-2 and bax
proteins mainly showed tubular and crescentic expression. This was significantly different for bcl-2 in tubules and bax in distal tubules
compared to the controls (P < 0.05). No significant difference between bax and bcl-2 expression was observed among patients. However
the mean values of the bcl-2/bax ratio, that is, the balance between survival and apoptosis, were significantly higher in crescents of the
severe histopathologic group and in distal tubules of the poor prognosis group (P < 0.05).
Conclusion: A higher bcl-2/bax ratio, that is relative to the predominance of cell survival in distal tubules and crescents in HSN, seems
to be a poor prognostic factor in children.
Key words: Apoptosis, bax, bcl-2, children, Henoch–Schönlein nephritis, prognosis

1. Introduction
Henoch–Schönlein purpura (HSP) is the most common
small vessel vasculitis of children. Renal involvement
determines the prognosis. In the pathogenesis of Henoch–
Schönlein nephritis (HSN), glomerular deposition of
abnormally glycosylated immunoglobulin A (IgA),
intraglomerular nitric oxide elevation, peroxidative
damage, apoptosis, and sclerosis are involved (1). The
b-cell lymphoma 2 (Bcl-2) gene family is an important
group of genes encoding a group of proapoptotic and
antiapoptotic regulatory proteins. The best known and
most extensively studied ones are antiapoptotic bcl-2 and
proapoptotic bcl-2 associated X (bax), which block each
other by heterodimerisation. Their relative expressions at
cellular level determine the fate of involved cells, either in
the direction of apoptosis or survival (2–5).
* Correspondence: kenanbek2000@yahoo.com
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In this study we investigated renal expression of these 2
proteins with opposing actions by immunohistochemical
methods in children with HSN and evaluated their
prognostic significance.
2. Materials and methods
2.1. Subjects
Twenty-two children with HSN who followed at the Dr
Sami Ulus Obstetrics and Children’s Hospital, Paediatric
Nephrology Department, in Ankara, Turkey, were enrolled
in the study. The American College of Rheumatology
criteria were used for the diagnosis of HSP (6). Patients
with another systemic disease, no adequate urinalysis
data, or no follow-up were excluded from the study.
In 2 patients a rebiopsy was performed because of the
progression of renal findings. Histopathologic findings
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were graded from Class I to Class VI according to severity,
as previously suggested (1). The clinical and laboratory
parameters were defined as follows: 1) haematuria: 5 or
more red blood cells per high power field in a centrifuged
specimen, or more than 10 red blood cells per microlitre
on microscopy without proteinuria; 2) mild proteinuria:
urinary protein excretion of 4–40 mg m–2 h–1; 3) nephrotic
range proteinuria: urinary protein > 40 mg m–2 h–1; 4)
acute nephritic syndrome: haematuria associated with at
least 2 of the following: raised serum urea or creatinine,
hypertension, and oliguria; and 5) nephrotic syndrome:
proteinuria > 40 mg m–2 h–1, with serum albumin level
below 2.5 g/dL and oedema. Hypertension was defined as
average systolic or diastolic blood pressure values greater
than or equal to the 95th percentile for age, sex, and height.
The Schwartz formula was used to estimate creatinine
clearance.
As the control group, the autopsy kidney materials
of 5 age-matched children who died due to extrarenal
pathologies were used. Patients were divided into 2 groups
according to histopathologic findings: those having
crescents of less than 50% (first 3 classes) and those
having crescents of >50% (Class >III). They were also
grouped according to their prognosis as being in complete
remission if all clinical and laboratory findings were
normal; partial remission if minimal renal involvement
with normal albumin, urea, and creatinine was present;
and unresponsive or progression if renal findings persisted
or deteriorated.
The study was approved by the hospital’s ethics
committee.
2.2. Immunohistochemical examination
Bcl-2 and bax specific staining was applied to 3–5 µm
sections of paraffin blocks of kidney tissue using the
human specific antigen kits suitable for the tissues held in
formol or paraffin (bax: Ab-1, clon 2D2, 1 kDa antigen; bcl2a: Ab-1, clon100/D5, 25–26 kDa antigen, NeoMarkers,
USA).
Expression of bcl-2 and bax proteins were scored
semiquantitatively between “0” and “+++” according to
the percentage of the stained cells by a pathologist blind
to the clinical features of the patients, as suggested by
Charalambous et al. (7). The bcl-2/bax ratio was calculated
by using the percentages of stained cells.
2.3. Statistical analysis
The chi-square test was used to compare the renal
expression of bax and bcl-2 in patient and control groups.
Kruskal–Wallis and Mann–Whitney U tests were used to
compare the means of the bcl-2/bax ratio between groups.
P < 0.05 was accepted as significant. SPSS 10.0 was used for
the statistical analyses.
3. Results
Kidney biopsies of 22 children (17 males, 5 females) with
HSN, aged between 6 and 15 years (mean: 11.04 ± 2.5),

were evaluated immunohistochemically. The mean followup time was 35.5 (6–140) months. Initial clinical findings
were palpable purpura in 22 patient (100%), gastrointestinal
involvement in 17 (78%), arthritis/arthralgia in 15 (68%),
oedema in 8 (36%), hypertension in 6 (27%), and central
nervous system involvement in 1 (4%). Laboratory tests
revealed an elevated erythrocyte sedimentation rate in
14 patients (63%), low C3 level in 2, and low C4 level in 3.
Serum IgA levels were high in 4 patients (18%), low in 1
(4%), and normal in 17 (78%). Group A beta haemolytic
streptococcus was isolated in 1 patient’s throat culture,
and in 8 patients, antistreptolysin-O antibody titres
were elevated. The number of glomeruli in specimens
ranged from 10 to 125 (mean: 33.6). IgA deposition was
detected in all biopsies, ranging from + to +++ (+: 8.4%,
++:54.1%, and +++:37.5%). Nephrotic (9 patients; 40%) or
nephrotic-nephritic (9 patients; 40%) presentations were
the most common types of renal involvement. Persistent
nonnephrotic proteinuria was shown by 3 patients (13%),
and 1 patient (4%) was nephritic. Histopathological
findings of the patients were Class I in 1, Class II in 5,
Class III in 10, Class IV in 4, and Class V in 2 patients.
There were no Class VI patients. Rebiopsy was performed
in 2 patients with Class V HSN with deteriorating kidney
functions who were unresponsive to treatment. These
second biopsies were also of Class V and were included
in the study. In 4 Class IV patients, the percentage and
types of crescents were as follows: 27 crescents in 54
glomeruli (50%, all cellular), 6 crescents in 11 glomeruli
(55%, all fibrous), 6 crescents in 10 glomeruli (60%, 4
fibrous, 2 cellular), and 7 crescents in 10 glomeruli (70%,
6 cellular, 1 fibrocellular). In 2 Class V patients and their
2 rebiopsies, crescent distribution was as follows: 25
crescents in 32 glomeruli (78%, 4 fibrous, 3 cellular, and 18
fibrocellular), 4 crescents in 35 glomeruli (11%, 2 fibrous
and 2 fibrocellular crescents, and 19 obsolescent glomeruli;
diagnosed as Class V due to chronicity findings), 36
crescents in 44 glomeruli (81%, 6 fibrous, 11 cellular, and
19 fibrocellular), and 49 crescents in 52 glomeruli (94%, 30
fibrous, 3 cellular, and 16 fibrocellular).
There were 9 patients with rapidly progressive
glomerulonephritis who were given triple therapy,
as suggested by Öner et al. (8). The patients with
gastrointestinal system involvement were given oral
prednisolone. The outcomes of treatment according to
histopathologic classes are given in the Table.
Bcl-2 and bax proteins mainly showed tubular and
crescentic expression (Figure 1). Other than crescents,
glomerular expression of bcl-2 and bax was detected only
in 1 patient. Therefore glomerular involvement was not
included in the statistical analysis. In the control group
there were no crescents, as expected, and minimal tubular
bcl-2 and bax expression was detected. In the patients
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Table. Treatment response rates according to histopathologic class.
Histopathologic classification

Prognosis

Class I

Remission
Partial remission

1

Class II

Class III

4

4

1

6

Class IV

Class V

3

Progression

1

2

A

B

Figure 1. Tubular (+++) and crescentic (+) immunostaining with bax (A: 100×) and bcl-2 (B: 400×).

significantly higher bcl-2 expression in proximal and distal
tubules, and bax expression in distal tubules, were detected,
both in the histopathologic and prognostic subgroups,
when compared to the controls (P < 0.05 for all). When
patients were compared with each other, no significant
difference was observed between the histopathologic or
prognostic subgroups. Therefore, the means of the bcl2/bax ratio, showing the balance between proapoptotic

and antiapoptotic proteins, were used for comparison.
For all sites (proximal tubules, distal tubules, crescents),
the means of the bcl-2/bax ratio were the highest in
higher histopathologic classes (Classes IV and V) and
the progression group. These differences were statistically
significant for crescentic expression in histopathologic
classes (P = 0.049) and for distal tubular expression in
prognostic groups (P = 0.045) (Figures 2 and 3).

3.5
3

bcl-2/bax means
P>0.05

P=0.045

P>0.05

2.5
bcl-2/bax means
3
2.5
2
1.5
1
0.5
0

P>0.05

P>0.05

P=0.049

1.5
1
0.5
0

PT
Control

DT
Class I-III

Crescent
Class IV-V

Figure 2. Means of bcl-2/bax ratio in patients according to their
histopathology (PT: proximal tubule, DT: distal tubule).
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PT
Control

DT
Partial remission

Crescent
Remission

Progression

Figure 3. Means of bcl-2/bax ratio in subjects according to their
prognosis (PT: proximal tubule, DT: distal tubule).
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4. Discussion
The degree of renal involvement in HSP determines
the prognosis (9–11). In our study, 3 patients (13.6%)
progressed to end-stage renal disease (ESRD). Multiple
factors, including apoptosis, are important in progression
to ESRD, but there are many unexplained or controversial
points about the role of apoptosis in renal diseases
(12–16). For example, in resolving postinfectious
glomerulonephritis, proliferation and cell death coincide.
However, in lupus nephritis, proliferation predominates.
Proliferative glomerulonephritis shows increased mitotic
activity in glomeruli or infiltrating inflammatory cells.
Thus, recovery of the lesions probably depends on
increased apoptotic removal of these cells (4,17). Our
results support this theory. This is because the significantly
increased bcl-2/bax ratio in crescents and distal tubules
of the patients with more severe histopathology, or with
poorer prognosis, indicates cell survival predominance
or insufficient apoptosis. In glomerular diseases bcl-2 is
responsible for hypercellularity while bax is important
for glomerulosclerosis. Thus, the balance between them
is critical for the progression of glomerular diseases.
Bcl-2 expression correlates with proliferation/activation
of mesangial cells (4,18,19). However, bax expression
correlates with mesangial matrix expansion and type-IV
collagen deposition. Therefore, their relative expression
is important in disease progression (4). Involvement of
oxidative stress and reactive oxygen molecules (ROMs)
in HSP is more indirect evidence for the role of apoptosis
in HSN pathogenesis. Besides, ROM levels are under the
control of the Bcl-2 gene product (20,21).
The mainly tubular expression of bax and bcl-2 in
our patients is in agreement with the literature (18,22).
However, the variable biopsy timing in our study is a
drawback and thus immunohistochemical findings may
represent different apoptotic stages. In order to alleviate
this limitation, we used the means of the bcl-2/bax ratio
instead of the individual expression of each protein, and
we found significantly higher means of the bcl-2/bax ratio
in crescents in the more severe histopathologic group. For
the prognostic groups, a significant increase was detected
in the means of the bcl-2/bax ratio in distal tubules, going
from favourable to poor prognosis groups.

In proliferative glomerulonephritis models, apoptosis
is important for the removal of hypercellularity in the
repair process (23). In our study, higher crescentic and
distal tubular bcl-2/bax ratios in severe histopathologic
or poor prognostic groups may represent the relative
predominance of cell survival, preventing repair at a
critical phase of HSN. In the remnant kidney model,
however, increased apoptosis is reported to be responsible
for scarring, tubular atrophy, or fibrosis (24). These
contradictory results might be due to the different roles
of apoptosis in different pathogenetic processes. In
proliferative inflammatory conditions of the kidney,
apoptosis is essential for resolution, but for resident kidney
cells, uncontrolled apoptosis is definitely harmful with the
potential risk of renal failure by reducing functional renal
mass (23,24). Our findings seem to contradict the results
of the nephrotoxic nephritis rat model of Yang et al. (25),
as well. They reported a strong increase in the bax/bcl-2
ratio in favour of apoptosis through caspase-3 activation.
However, they also reported differences between mRNA
and tissue expression of these proteins, and they attributed
this to further translational or posttranslational control
mechanisms within the diseased kidney.
Apoptosis is a complex and dynamic process with many
pathways and regulatory proteins involved. Expression
of a single molecule might not necessarily represent the
dominant pathway in that moment, since a kidney biopsy
provides a static picture of the pathogenesis of a specific
disease. Despite all these limitations, to our knowledge,
this is the first study investigating the renal expression of
these 2 proteins in the most frequent vasculitis of children.
In conclusion, our results indicate, but do not prove,
that insufficient apoptosis or prolonged cell survival in
crescents and distal tubules at a critical and probably
proliferative stage of HSN in children is associated with an
unfavourable histology and a poor prognosis.
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